Recognizing the explosion in clinical factors affecting the outcome and diagnosis of disease, Lincoln Berland, MD, played an instrumental role in the development of clinical criteria beginning in 2006. As then-chair of the ACR Abdominal Imaging Committee, and with the support of the ACR, he organized the ACR Incidental Findings Committee.

The use of patients’ pre-existing full-field digital breast mammography (FFMD) and current digital breast tomosynthesis (DBT) images are largely independent contributing factors for reducing mammography recall rates in noncancer cases, according to results of a study published online March 21 in the journal Radiology.

Adult patients who score a “3” or lower on the Alvarado point-scale should not be considered at risk for appendicitis and are unlikely to benefit from additional CT testing, according to results of a study published in the March issue of the American Journal of Roegentology.

A MR spectroscopy technique has been shown capable of detecting preinvasive biochemical changes in women genetically predisposed to breast cancer, which could improve clinical monitoring and management of high-risk patients, according to a study published online March 3 in the Radiology.

With the push for breast density notification laws around the country, more patients are being recommended for supplemental screening. Ultrasound is a top choice for this purpose, and it should be available to all women, according to a recent editorial published in Forbes.

Adding white blood cell count and polymorphonuclear leukocyte differential to already existing ultrasound screening technology improves predictive diagnosis of appendicitis in children, according to a study published online Jan. 31 in the Journal of the American College of Surgeons.

ROCHESTER, N.Y., Feb. 26 — Carestream Health’s newest DRX imaging system—the CARESTREAM DRX-Evolution Plus—adds several major software and hardware enhancements to meet the changing radiology needs and budgets of healthcare providers worldwide.

At ECR 2015 Esaote, a world leading manufacturer of medical diagnostic systems, introduces Evolution’15 (EVO’15) as the latest upgrade in its dedicated MRI Evolution program. EVO’15 combines software updates and new hardware features to provide superb image quality and increases productivity by almost 50 percent.